Kit for detecting laryngeal squamous cell carcinoma radiotherapy sensitivity related gene ATM and ATR gene mutation and application of kit
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- EYE & ENT HOSPITAL SHANGHAI MEDICAL SCHOOL FUDAN UNIV
- Publication Date
- 2021-12-07
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to the technical field of molecular diagnosis, in particular to a kit for detecting mutations of genes ATM and ATR related to radiosensitivity of laryngeal squamous cell carcinoma and its application. Background technique
[0002] Laryngeal cancer is a high-incidence tumor of the head and neck, and squamous cell carcinoma is its most common pathological type. Radiotherapy is one of the main treatment methods for laryngeal squamous cell carcinoma, and it has a very good therapeutic effect on most patients with laryngeal squamous cell carcinoma. However, in some patients with throat cancer, radiation therapy does not respond well. If the radiosensitivity of a patient's tumor can be judged as early as possible, it can be accurately judged whether the patient is suitable for radiotherapy, thereby guiding clinical practice, and greatly improving the prognosis of patients, reducing unnecessary costs for patients and waste of medical re...